Physician profile
Ankur Gupta
NPI 1447647276
$2,028.34
in general payments reported to CMS, 2019-2025
21 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $68.70 · 2021: $115 · 2022: $38.46 · 2023: $460 · 2024: $326 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,262 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,261.60 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $525.08 | 2019-2025 | Argos, Eysuvis, Clareon |
| Astellas Pharma US INC | $208.51 | 2023-2024 | Izervay |
| Edwards Lifesciences Corporation | $200.43 | 2019 | |
| Bausch & Lomb Americas INC. | $175.67 | 2022-2025 | Vyzulta, Miebo, Xiidra |
| Apellis Pharmaceuticals, INC. | $144.77 | 2024-2025 | Syfovre |
| Glaukos Corporation | $135.61 | 2019-2024 | Idose |
| Sight Sciences, INC. | $135.38 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $120.97 | 2025 | Veritas Vision System |
| Oyster Point Pharma, INC. | $73.80 | 2023-2025 | Tyrvaya, Ryzumvi |
| Abiomed | $49.99 | 2020 | |
| Rxsight INC | $34.33 | 2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Dompe US, INC. | $33.44 | 2025 | Oxervate |
| Boston Scientific Corporation | $32.12 | 2019 | |
| Ani Pharmaceuticals, INC. | $28.10 | 2023 | Purified Cortrophin Gel |
| Harrow Eye, LLC | $22.53 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $22.43 | 2025 | Streamline, Clearpath, Via360 |
| Ocular Therapeutix, INC. | $18.71 | 2020 | |
| Sun Pharmaceutical Industries INC. | $18.54 | 2021 | |
| Abbott Laboratories | $18.50 | 2019 | |
| Lensar, INC. | $17.48 | 2024 | Lensar Laser System |
| Tearlab Corp | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.